When should men get screened for prostate cancer? Experts discuss the guidance

Former President Joe Biden’s recent aggressive prostate cancer diagnosis has sparked a debate about the importance of prevention and detection. The U.S. Preventive Services Task Force (USPSTF) recommends that men aged 55 to 69 should discuss the potential benefits and risks of PSA (prostate-specific antigen) screening with their healthcare provider. It is crucial for men in this age group to have an informed discussion with their healthcare provider to make a shared decision about screening.

Dr. Shawn Dason, a urologic oncologist at The Ohio State University Comprehensive Cancer Center, emphasized the importance of men in their 50s and 60s engaging in conversations with their healthcare providers about prostate cancer screening. It is essential for men to understand the potential benefits and harms of screening before making a decision.

The potential risks of screening and treatment should also be considered. Over-treatment or unnecessary treatment are possible risks, as some men may receive treatment for prostate cancer that may not have led to death or other clinical problems. This can result in bothersome side effects such as urinary, sexual, or bowel-related issues. It is crucial for men to weigh the potential benefits of screening against the risks of treatment.

While the USPSTF recommends that men over the age of 70 skip screenings altogether, there is some variability in whether men under 50 and over 70 should be screened. Dason highlighted the importance of having a discussion with a healthcare provider to determine the best course of action based on individual risk factors.

Dr. Marc Siegel, Fox News’ senior medical analyst, expressed concerns about the guidelines not recommending routine prostate cancer screening for men over the age of 70. He emphasized the importance of early diagnosis and intervention, especially considering the high number of new prostate cancer cases diagnosed each year.

Siegel advocated for all men over the age of 45 to undergo prostate cancer screening, regardless of age. He noted that treatment options have advanced over the years, making them better tolerated with fewer side effects for patients at various stages and ages.

Dason agreed that some men aged 70 and older may be appropriate candidates for screening, particularly if they are in good health with a reasonable life expectancy. It is essential for men to consider their individual health situation and have a discussion with their healthcare provider to determine the best course of action.

In conclusion, the debate surrounding prostate cancer screening underscores the importance of informed decision-making and individualized care. Men should be proactive about discussing screening options with their healthcare providers to ensure early detection and appropriate treatment. Early intervention can significantly impact outcomes and improve quality of life for those diagnosed with prostate cancer.